StreetInsider.com News Articles

CVRx board responds to shareholder letter on valuation concerns

Tue, 25 Aug 2026 08:04:12 -0400

CVRx, Inc. (NASDAQ: CVRX) issued a statement on Aug. 25, 2026, responding to a public letter from Jorey Chernett of Pointillist Family Office, addressed to CVRx's Board of Directors and dated Aug. 24, 2026.

In its statement, the CVRx board said it "regularly evaluates a full range of options to maximize value for all shareholders" and acknowledged an "open dialogue" with Chernett.

The company said it agrees with Chernett's characterization of its Barostim device as a "highly differentiated, validated therapy" and that CVRx's current valuation "does not fully capture the potential of the underlying business." The board added it is "confident in

CVRx board responds to shareholder letter on valuation concerns

Tue, 25 Aug 2026 08:04:12 -0400

In its statement, the CVRx board said it "regularly evaluates a full range of options to maximize value for all shareholders" and acknowledged an "open dialogue" with Chernett.

CVRx Responds to Letter from Pointillist Family Office

Tue, 25 Aug 2026 08:00:00 -0400

MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today issued the following statement in response to the public letter to CVRx’s Board of Directors from Jorey Chernett at Pointillist Family Office, dated August 24, 2026:

The Board of Directors and leadership team are committed to acting in the best interests of all CVRx shareholders and regularly evaluate a full range of options to maximize value for all shareholders. The Board values all shareholder input

CVRx Responds to Letter from Pointillist Family Office

Tue, 25 Aug 2026 08:00:00 -0400

CVRx Responds to Letter from Pointillist Family Office

Tue, 25 Aug 2026 08:00:00 -0400

CVRx Responds to Letter from Pointillist Family Office

Tue, 25 Aug 2026 08:00:00 -0400

Form SCHEDULE 13D CVRx, Inc. Filed by: Chernett Jorey

Mon, 24 Aug 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260824/26969532.html

Form SCHEDULE 13D CVRx, Inc. Filed by: Chernett Jorey

Mon, 24 Aug 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260824/26969532.html

CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP

Mon, 24 Aug 2026 11:21:00 -0400

Boston, Massachusetts--(Newsfile Corp. - August 24, 2026) - Block & Leviton is investigating CVRx, Inc. (NASDAQ: CVRX) for potential securities law violations. Investors who have lost money in their CVRx, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cvrx.

What is this all about?

Block & Leviton is investigating whether CVRx and certain of its executives misrepresented or failed to timely disclose material information about the company's sales execution, growth, and revenue outlook. On August 6, 2026, CVRx cut its full-year revenue guidance to $58-60 million from a prior

CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP

Mon, 24 Aug 2026 11:21:00 -0400

What is this all about?

CVRx shareholder pushes board to pursue sale of the company

Mon, 24 Aug 2026 08:32:31 -0400

Jorey Chernett, founder of Pointillist Family Office and beneficial owner of more than 5.5% of outstanding shares of CVRx, Inc. (NASDAQ: CVRX), has delivered a letter to the CVRx board of directors urging it to launch a formal process to sell the company to a strategic acquirer.

In the letter, Chernett argues that CVRx's Barostim product would be valuable to a large medical device company and that a sale could be accretive to an acquirer within twelve months. He contends that a sale would allow CVRx shareholders to realize value that the company cannot deliver on a standalone basis.

Chernett's letter calls

CVRx shareholder pushes board to pursue sale of the company

Mon, 24 Aug 2026 08:32:31 -0400

Chernett's letter calls

CVRx shareholder pushes board to pursue sale of the company

Mon, 24 Aug 2026 08:32:31 -0400

Chernett's letter calls

Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer